![Mark Plavsic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Plavsic
Hoofd Techniek/Wetenschap/O&O bij
AURA BIOSCIENCES, INC.
Vermogen: 2 M $ op 31-05-2026
Profiel
Dr. Mark Plavsic is Chief Technical Officer bij Fate Therapeutics, Inc. Dr. Plavsic was voordien werkzaam als Chief Technical Officer bij Lysogene SA en als Head- Process Development & Manufacturing bij Torque Therapeutics, Inc. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Belgrado en een doctoraatsdiploma aan de Universiteit van Belgrado.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,39% | 02-03-2026 | 243.736 ( 0,39% ) | 2 M $ | 31-05-2026 |
Actieve functies van Mark Plavsic
| Bedrijven | Functie | Begin |
|---|---|---|
| AURA BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 02-10-2023 |
TeraPore Technologies, Inc.
 TeraPore Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and distributes filters for protein separations | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mark Plavsic
| Bedrijven | Functie | Einde |
|---|---|---|
| FATE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 06-03-2023 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Corporate Officer/Principal | - |
| LYSOGENE | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Mark Plavsic
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
University of Belgrade
 University of Belgrade Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
TeraPore Technologies, Inc.
TeraPore Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and distributes filters for protein separations | Process Industries |
